Zhejiang Chinese Medicine University, Hangzhou, China.
School of Public Health, Lanzhou University, Lanzhou, China.
Pharmacol Res. 2021 Dec;174:105955. doi: 10.1016/j.phrs.2021.105955. Epub 2021 Oct 29.
Severe Coronavirus Disease 2019 (COVID-19) is characterized by numerous complications, complex disease, and high mortality, making its treatment a top priority in the treatment of COVID-19. Integrated traditional Chinese medicine (TCM) and western medicine played an important role in the prevention, treatment, and rehabilitation of COVID-19 during the epidemic. However, currently there are no evidence-based guidelines for the integrated treatment of severe COVID-19 with TCM and western medicine. Therefore, it is important to develop an evidence-based guideline on the treatment of severe COVID-19 with integrated TCM and western medicine, in order to provide clinical guidance and decision basis for healthcare professionals, public health personnel, and scientific researchers involved in the diagnosis, treatment, and care of COVID-19 patients. We developed and completed the guideline by referring to the standardization process of the "WHO handbook for guideline development", the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, and the Reporting Items for Practice Guidelines in Healthcare (RIGHT).
严重的 2019 年冠状病毒病(COVID-19)的特点是并发症众多、病情复杂且死亡率高,因此其治疗成为 COVID-19 治疗的重中之重。在疫情期间,中西医结合在 COVID-19 的预防、治疗和康复中发挥了重要作用。然而,目前尚无针对 COVID-19 重症患者采用中西医结合治疗的循证指南。因此,制定一份关于 COVID-19 重症患者采用中西医结合治疗的循证指南非常重要,以便为参与 COVID-19 患者诊断、治疗和护理的医疗保健专业人员、公共卫生人员和科研人员提供临床指导和决策依据。我们参考了“世界卫生组织指南制定手册”、推荐评估、制定和评价(GRADE)系统以及医疗保健实践指南报告项目(RIGHT)的标准化流程来制定和完成本指南。